BCYC - Bicycle Therapeutics EPS beats by $0.26 beats on revenue March, 10 2020 07:02 AM Bicycle Therapeutics plc Bicycle Therapeutics (NASDAQ:BCYC): Q4 GAAP EPS of -$0.25 beats by $0.26.Revenue of $5.28M (+398.1% Y/Y) beats by $4.56M.Press ReleaseMore news on: Bicycle Therapeutics plc, Earnings news and commentary, Healthcare stocks news,